Q2 2014 Earnings Conference Call July 21, 2014, 10:30 AM ET Executives Jim Hindman - SVP, Treasury, Risk & IR David Pyott - Chairman & CEO Jeff Edwards - EVP, Finance & Business Development, CFO Scott Whitcup - EVP, R&D, Chief Scientific
management possesses impressive research and development acumen, which supports long-term growth opportunities. David Pyott , having held his position since 1998, follows as another long-serving CEO. Pyott previously headed the nutrition
SAN DIEGO (Reuters) - Allergan Inc , seeking to win over shareholders as it fights a hostile takeover offer from Valeant Pharmaceuticals International Inc , will raise its earnings outlook when it reports second-quarter results, said Chief Executive Officer David Pyott .
Michael Pearson, the CEO of Valeant, claims that his fillers gained market share. At the same time, Allergan's CEO, David Pyott , says Valeant lost filler market share dramatically. Here are their respective quotes. Michael Pearson from Valeant's
its ally, hedge fund billionaire William Ackman."I'm an endurance player; I climbed Kilmanjaro last year," David Pyott said in a telephone interview, when asked if he was prepared to battle Valeant and Ackman possibly into next year
BRK-A/B, DIS, GPS, JNJ, MCK, PAYX, PEP, PFE, PM, UNP ; pg 34]; Allergan [ AGN ; the CEO spotlight on David Pyott ; pg 36]. KO story http://online.barrons.com/article/SB50001424053111904742804579282313576005116.html